                         SEQUENCE LISTING

<110>  QUEEN MARY UNIVERSITY OF LONDON
 
<120>  TREATMENT

<130>  N417173WO

<140>
<141>

<150>  GB1911816.5
<151>  2019-08-16

<160>  46    

<170>  PatentIn version 3.5

<210>  1
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  N-methylated

<400>  1

Arg Gly Asp Ala Ala Ala 
1               5       


<210>  2
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  2

Ala Arg Gly Asp Ala Ala 
1               5       


<210>  3
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  N methylated

<400>  3

Arg Gly Asp Ala Ala Ala 
1               5       


<210>  4
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  4

Arg Gly Asp Ala Ala Ala 
1               5       


<210>  5
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  5

Val Arg Gly Asp Ala Ala 
1               5       


<210>  6
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  6

Phe Arg Gly Asp Ala Ala 
1               5       


<210>  7
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  N methylated

<400>  7

Arg Gly Asp Ala Ala Val 
1               5       


<210>  8
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  N methylated

<400>  8

Arg Gly Asp Ala Ala Phe 
1               5       


<210>  9
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Methyl ester (OMe) moiety

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  9

Val Arg Gly Asp Ala Ala 
1               5       


<210>  10
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Methyl ester (OMe) moiety

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  10

Ala Arg Gly Asp Ala Ala 
1               5       


<210>  11
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Methyl ester (OMe) moiety

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  N methylated

<400>  11

Arg Gly Asp Ala Ala Ala 
1               5       


<210>  12
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Methyl ester (OMe) moiety

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  12

Arg Gly Asp Ala Ala Ala 
1               5       


<210>  13
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  13

Arg Gly Asp Ala Ala Ala 
1               5       


<210>  14
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Methyl ester (OMe) moiety

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  14

Phe Arg Gly Asp Ala Ala 
1               5       


<210>  15
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<400>  15

Leu Pro Pro Phe Arg Gly Asp Leu Ala 
1               5                   


<210>  16
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<400>  16

Leu Pro Pro Gly Leu Arg Gly Asp 
1               5               


<210>  17
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  17

Leu Pro Pro Phe Arg Gly Asp Leu Ala 
1               5                   


<210>  18
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  18

Leu Pro Pro Gly Leu Arg Gly Asp 
1               5               


<210>  19
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<400>  19

Ala Ala Ala Ala Ala Ala 
1               5       


<210>  20
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  N methylated

<400>  20

Phe Val Arg Gly Asp 
1               5   


<210>  21
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Hexyloxycarbonyl (Hoc) moiety

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Methyl ester (OMe) moiety

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  21

Val Arg Gly Asp Ala Ala 
1               5       


<210>  22
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  N methylayed

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<400>  22

Ala Ala Ala Ala Ala Ala 
1               5       


<210>  23
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<400>  23

Phe Val Arg Gly Asp 
1               5   


<210>  24
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-methylated

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  N-methylated

<400>  24

Arg Gly Asp Ala Ala Ala 
1               5       


<210>  25
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  25

Ala Arg Gly Asp Ala Ala 
1               5       


<210>  26
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  N methylated

<400>  26

Arg Gly Asp Ala Ala Ala 
1               5       


<210>  27
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  27

Arg Gly Asp Ala Ala Ala 
1               5       


<210>  28
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  28

Val Arg Gly Asp Ala Ala 
1               5       


<210>  29
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  29

Phe Arg Gly Asp Ala Ala 
1               5       


<210>  30
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  N methylated

<400>  30

Arg Gly Asp Ala Ala Val 
1               5       


<210>  31
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  N methylated

<400>  31

Arg Gly Asp Ala Ala Phe 
1               5       


<210>  32
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Methyl ester (OMe) moiety

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  32

Val Arg Gly Asp Ala Ala 
1               5       


<210>  33
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Methyl ester (OMe) moiety

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  33

Ala Arg Gly Asp Ala Ala 
1               5       


<210>  34
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Methyl ester (OMe) moiety

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  N methylated

<400>  34

Arg Gly Asp Ala Ala Ala 
1               5       


<210>  35
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Methyl ester (OMe) moiety

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  35

Arg Gly Asp Ala Ala Ala 
1               5       


<210>  36
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  36

Arg Gly Asp Ala Ala Ala 
1               5       


<210>  37
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Methyl ester (OMe) moiety

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  37

Phe Arg Gly Asp Ala Ala 
1               5       


<210>  38
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<400>  38

Leu Pro Pro Phe Arg Gly Asp Leu Ala 
1               5                   


<210>  39
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<400>  39

Leu Pro Pro Gly Leu Arg Gly Asp 
1               5               


<210>  40
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide

<400>  40

Leu Pro Pro Phe Arg Gly Asp Leu Ala 
1               5                   


<210>  41
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide

<400>  41

Leu Pro Pro Gly Leu Arg Gly Asp 
1               5               


<210>  42
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<400>  42

Ala Ala Ala Ala Ala Ala 
1               5       


<210>  43
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  N methylated

<400>  43

Phe Val Arg Gly Asp 
1               5   


<210>  44
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Hexyloxycarbonyl (Hoc) moiety

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Methyl ester (OMe) moiety

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  N methylated

<400>  44

Val Arg Gly Asp Ala Ala 
1               5       


<210>  45
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  N methylayed

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<400>  45

Ala Ala Ala Ala Ala Ala 
1               5       


<210>  46
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  N methylated

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Two hexyloxycarbonyl (Hoc) moieties

<400>  46

Phe Val Arg Gly Asp 
1               5   


